WO2002012523A3 - Vecteurs d'apport de gene a specificite de type cellulaire pour chondrocytes humains primaires - Google Patents
Vecteurs d'apport de gene a specificite de type cellulaire pour chondrocytes humains primaires Download PDFInfo
- Publication number
- WO2002012523A3 WO2002012523A3 PCT/NL2001/000595 NL0100595W WO0212523A3 WO 2002012523 A3 WO2002012523 A3 WO 2002012523A3 NL 0100595 W NL0100595 W NL 0100595W WO 0212523 A3 WO0212523 A3 WO 0212523A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chondrocytes
- transduction
- adenoviral vectors
- nucleic acid
- delivery vehicle
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10345—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6009—Vectors comprising as targeting moiety peptide derived from defined protein from viruses dsDNA viruses
- C12N2810/6018—Adenoviridae
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01974977A EP1307573B1 (fr) | 2000-08-10 | 2001-08-09 | Vecteurs adenoviraux pour la transduction de chondrocytes |
CA2418977A CA2418977C (fr) | 2000-08-10 | 2001-08-09 | Vecteurs de transfert de genes presentant une specificite vis-a-vis des chondrocytes humains primaires |
AU9434801A AU9434801A (en) | 2000-08-10 | 2001-08-09 | Gene delivery vectors with cell type specificity for primary human chondrocytes |
DE60116513T DE60116513T2 (de) | 2000-08-10 | 2001-08-09 | Adenovirenvektoren zur transduktion der chondrozyten |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00202835.5 | 2000-08-10 | ||
EP00202835 | 2000-08-10 | ||
US22491100P | 2000-08-11 | 2000-08-11 | |
US60/224,911 | 2000-08-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002012523A2 WO2002012523A2 (fr) | 2002-02-14 |
WO2002012523A3 true WO2002012523A3 (fr) | 2002-04-25 |
Family
ID=26072592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL2001/000595 WO2002012523A2 (fr) | 2000-08-10 | 2001-08-09 | Vecteurs d'apport de gene a specificite de type cellulaire pour chondrocytes humains primaires |
Country Status (8)
Country | Link |
---|---|
US (2) | US6803234B2 (fr) |
EP (1) | EP1307573B1 (fr) |
AT (1) | ATE315095T1 (fr) |
AU (1) | AU9434801A (fr) |
CA (1) | CA2418977C (fr) |
DE (1) | DE60116513T2 (fr) |
ES (1) | ES2256302T3 (fr) |
WO (1) | WO2002012523A2 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030017138A1 (en) * | 1998-07-08 | 2003-01-23 | Menzo Havenga | Chimeric adenoviruses |
US20060238702A1 (en) | 1999-04-30 | 2006-10-26 | Advanced Medical Optics, Inc. | Ophthalmic lens combinations |
US6492169B1 (en) | 1999-05-18 | 2002-12-10 | Crucell Holland, B.V. | Complementing cell lines |
EP1157999A1 (fr) * | 2000-05-24 | 2001-11-28 | Introgene B.V. | Méthodes et moyens pour améliorer la transplantation de la peau en utilisant des vecteurs d'apport de genes munis d'un tropisme pour des fibroblastes primaires ainsi que d'autres utilisations de celles-ci |
ATE315095T1 (de) * | 2000-08-10 | 2006-02-15 | Crucell Holland Bv | Adenovirenvektoren zur transduktion der chondrozyten |
US7763069B2 (en) | 2002-01-14 | 2010-07-27 | Abbott Medical Optics Inc. | Accommodating intraocular lens with outer support structure |
US7662180B2 (en) | 2002-12-05 | 2010-02-16 | Abbott Medical Optics Inc. | Accommodating intraocular lens and method of manufacture thereof |
US7927599B2 (en) | 2003-09-08 | 2011-04-19 | Ethicon, Inc. | Chondrocyte therapeutic delivery system |
US8257963B2 (en) | 2007-06-01 | 2012-09-04 | Depuy Mitek, Inc. | Chondrocyte container and method of use |
US7897384B2 (en) * | 2003-09-08 | 2011-03-01 | Ethicon, Inc. | Chondrocyte therapeutic delivery system |
US20050131535A1 (en) | 2003-12-15 | 2005-06-16 | Randall Woods | Intraocular lens implant having posterior bendable optic |
CN100361710C (zh) * | 2004-06-07 | 2008-01-16 | 成都康弘生物科技有限公司 | 肿瘤细胞专一表达免疫调节因子gm-csf的溶瘤性腺病毒重组体的构建及其应用 |
WO2006061824A2 (fr) * | 2004-12-06 | 2006-06-15 | Prochon Biotech Limited | Implant a base de chondrocytes pour l'administration d'agents therapeutiques |
US8921109B2 (en) | 2005-09-19 | 2014-12-30 | Histogenics Corporation | Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
US9636213B2 (en) | 2005-09-30 | 2017-05-02 | Abbott Medical Optics Inc. | Deformable intraocular lenses and lens systems |
US20080161914A1 (en) | 2006-12-29 | 2008-07-03 | Advanced Medical Optics, Inc. | Pre-stressed haptic for accommodating intraocular lens |
US20090054984A1 (en) | 2007-08-20 | 2009-02-26 | Histogenics Corporation | Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects |
US8685107B2 (en) | 2007-07-03 | 2014-04-01 | Histogenics Corporation | Double-structured tissue implant and a method for preparation and use thereof |
US8034108B2 (en) | 2008-03-28 | 2011-10-11 | Abbott Medical Optics Inc. | Intraocular lens having a haptic that includes a cap |
AU2010266020B2 (en) | 2009-06-26 | 2015-03-26 | Johnson & Johnson Surgical Vision, Inc. | Accommodating intraocular lenses |
US8343217B2 (en) | 2009-08-03 | 2013-01-01 | Abbott Medical Optics Inc. | Intraocular lens and methods for providing accommodative vision |
CA2857087C (fr) | 2011-11-28 | 2021-05-25 | Crucell Holland B.V. | Vaccins contre le virus de la grippe et leurs utilisations |
US9084674B2 (en) | 2012-05-02 | 2015-07-21 | Abbott Medical Optics Inc. | Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity |
EP2971008B1 (fr) | 2013-03-14 | 2018-07-25 | Salk Institute for Biological Studies | Compositions d'adénovirus oncolytiques |
US10077420B2 (en) | 2014-12-02 | 2018-09-18 | Histogenics Corporation | Cell and tissue culture container |
EP3390428B1 (fr) | 2016-02-23 | 2019-09-25 | Salk Institute for Biological Studies | Dosage à haut débit pour mesurer la cinétique de réplication d'un adénovirus |
KR102471633B1 (ko) | 2016-02-23 | 2022-11-25 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 바이러스 동역학에 미치는 영향 최소화를 위한 치료용 아데노바이러스의 외인성 유전자 발현 |
AU2017375633C1 (en) | 2016-12-12 | 2023-04-27 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
AU2018330604A1 (en) | 2017-09-11 | 2020-04-02 | Amo Groningen B.V. | Methods and apparatuses to increase intraocular lenses positional stability |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000003029A2 (fr) * | 1998-07-08 | 2000-01-20 | Introgene B.V. | Adenovirus chimeres |
WO2000052186A1 (fr) * | 1999-03-04 | 2000-09-08 | Introgene B.V. | Transduction de cellules ressemblant a des fibroblastes ou a des macrophages et moyens a cet effet |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
CA2342396A1 (fr) * | 1998-09-11 | 2000-03-23 | Genvec, Inc. | Adenovirus a ciblage altnernatif |
US6869936B1 (en) * | 1999-03-04 | 2005-03-22 | Crucell Holland B.V. | Means and methods for fibroblast-like or macrophage-like cell transduction |
US6315992B1 (en) * | 1999-06-30 | 2001-11-13 | Tissuegene Co. | Generating cartilage in a mammal using fibroblasts transfected with a vector encoding TGF-β-1 |
US6445314B1 (en) * | 2000-03-01 | 2002-09-03 | Cisco Technology Inc. | System and method for the decoding of variable length codes |
US6939540B1 (en) * | 2000-07-31 | 2005-09-06 | Cornell Research Foundation, Inc. | Method of enhancing bone density |
ATE315095T1 (de) * | 2000-08-10 | 2006-02-15 | Crucell Holland Bv | Adenovirenvektoren zur transduktion der chondrozyten |
-
2001
- 2001-08-09 AT AT01974977T patent/ATE315095T1/de active
- 2001-08-09 EP EP01974977A patent/EP1307573B1/fr not_active Expired - Lifetime
- 2001-08-09 AU AU9434801A patent/AU9434801A/xx not_active Withdrawn
- 2001-08-09 ES ES01974977T patent/ES2256302T3/es not_active Expired - Lifetime
- 2001-08-09 DE DE60116513T patent/DE60116513T2/de not_active Expired - Lifetime
- 2001-08-09 WO PCT/NL2001/000595 patent/WO2002012523A2/fr active IP Right Grant
- 2001-08-09 CA CA2418977A patent/CA2418977C/fr not_active Expired - Lifetime
- 2001-08-10 US US09/928,262 patent/US6803234B2/en not_active Expired - Lifetime
-
2004
- 2004-02-17 US US10/779,915 patent/US20040142472A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000003029A2 (fr) * | 1998-07-08 | 2000-01-20 | Introgene B.V. | Adenovirus chimeres |
WO2000052186A1 (fr) * | 1999-03-04 | 2000-09-08 | Introgene B.V. | Transduction de cellules ressemblant a des fibroblastes ou a des macrophages et moyens a cet effet |
Non-Patent Citations (10)
Title |
---|
ARTHRITIS AND RHEUMATISM, (2000 MAY) 43 (5) 1156-64. * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1995, BARAGI VIJAYKUMAR M ET AL: "Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation.", XP002162078, Database accession no. PREV199698588719 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1996, DUPREZ DELPHINE ET AL: "Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb.", XP002162080, Database accession no. PREV199699148352 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1997, ARAI YUJI ET AL: "Adenovirus vector-mediated gene transduction to chondrocytes: In vitro evaluation of therapeutic efficacy of transforming growth factor-beta-1 and heat shock protein 70 gene transduction.", XP002162076, Database accession no. PREV199799748286 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; August 1999 (1999-08-01), ARAI YUJI ET AL: "Control of delivered gene expression in chondrocytes using heat shock protein 70B promoter.", XP002162077, Database accession no. PREV199900386530 * |
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; SMITH P ET AL: "Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin -1.", XP002162079, retrieved from STN Database accession no. 2000275271 * |
JOURNAL OF CLINICAL INVESTIGATION, vol. 96, no. 5, 1995, pages 2454 - 2460, ISSN: 0021-9738 * |
JOURNAL OF RHEUMATOLOGY, vol. 24, no. 9, 1997, pages 1787 - 1795, ISSN: 0315-162X * |
JOURNAL OF RHEUMATOLOGY, vol. 26, no. 8, August 1999 (1999-08-01), pages 1769 - 1774, ISSN: 0315-162X * |
MECHANISMS OF DEVELOPMENT, vol. 57, no. 2, 1996, pages 145 - 157, ISSN: 0925-4773 * |
Also Published As
Publication number | Publication date |
---|---|
DE60116513D1 (de) | 2006-03-30 |
ES2256302T3 (es) | 2006-07-16 |
ATE315095T1 (de) | 2006-02-15 |
US20020115218A1 (en) | 2002-08-22 |
WO2002012523A2 (fr) | 2002-02-14 |
US6803234B2 (en) | 2004-10-12 |
AU9434801A (en) | 2002-02-18 |
CA2418977C (fr) | 2011-01-18 |
CA2418977A1 (fr) | 2002-02-14 |
EP1307573A2 (fr) | 2003-05-07 |
EP1307573B1 (fr) | 2006-01-04 |
DE60116513T2 (de) | 2006-09-21 |
US20040142472A1 (en) | 2004-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002012523A3 (fr) | Vecteurs d'apport de gene a specificite de type cellulaire pour chondrocytes humains primaires | |
PT1080202E (pt) | Distribuicao de vectores aav codificando aadc intensificada por conveccao | |
PL404537A1 (pl) | Wirusy stowarzyszone z adenowirusem, kompozycje, wyizolowane bialko kapsydu, wyizolowana lub syntetyczna czasteczka kwasu nukleinowego, sposób wytwarzania rekombinowanych wirusów, komórki gospodarza, bialka obejmujace fragment bialka kapsydu AAV, sztuczne bialka, rekombinowane wirusy, czasteczki, sposoby dostarczania transgenu do komórki, sposób identyfikacji serotypu sekwencji wirusa (AAV), zestaw diagnostyczny, sposób izolacji nowych wirusów, nowe serotypy wirusa, wyizolowane wirusy, rekombinowana komórka, zastosowanie wirusa | |
EP1009814A4 (fr) | Tyrosine kinase receptrice, kdr | |
ATE405295T1 (de) | Verbesserte raav-expressionssysteme für die genetische modifikation spezifischer capsidproteine | |
AU7381098A (en) | Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same | |
DK1783225T3 (da) | Strukturprotein fra AAV, dets fremstilling og anvendelse | |
DE69833784D1 (de) | Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren | |
HK1039795A1 (zh) | 能在心臟中組織特異性表達的重組腺病毒 | |
IL122206A0 (en) | Adeno-associated virus vectors for gene expression | |
WO2003042362A3 (fr) | Pgc-1$g(b), un nouvel homologue du pgc-1 et leurs utilisations | |
DE69535696D1 (de) | Tripeptidyl-aminopeptidase | |
NZ500540A (en) | Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae | |
AU7489098A (en) | Polypeptides having aminopeptidase activity and nucleic acids encoding same | |
WO2003008449A8 (fr) | Ntb-a, une molecule de surface impliquee dans l'activite des cellules tueuses naturelles | |
MXPA04004561A (es) | Distribuidor de aire para sistema de biolixiviacion. | |
EP0832266A4 (fr) | Administration orale de vecteurs du virus associe a l'adenovirus | |
EP1412374A4 (fr) | Nouveaux isoformes de pgc-1 et applications de ceux-ci | |
WO2002083857A3 (fr) | 68723, membres de la famille des cotransporteurs de sodium/glucose et utilisations associees | |
MXPA01004353A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
AU2001253258A1 (en) | Human trp-like calcium channel protein-2 (tlcc-2) | |
MXPA03002557A (es) | Interactores de canales del potasio y sus usos. | |
EP1430070A4 (fr) | Nouvelle proteine cark et molecules d'acides nucleiques et leurs utilisation | |
ATE346926T1 (de) | Menschliche twik-8 moleküle und ihre verwendung | |
AU2002234132A1 (en) | 13245, a novel human myotonic dystrophy type protein kinase and uses therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 523984 Country of ref document: NZ Ref document number: 2001294348 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001974977 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2418977 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2001974977 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 523984 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 523984 Country of ref document: NZ |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001974977 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001294348 Country of ref document: AU |